Will Ransomware Remain the Attack of Choice for Cybercriminals?

It is often said that crime doesn’t pay. That might not apply to the world of cybercrime. In 2020, research from Atlas VPN found that cybercrime earned $1.5 trillion dollars in revenue. One approach to cybercrime that has seemed to grow in popularity as of late, despite being around for a while, is ransomware. We asked Matt Rider, Vice President of Sales Engineering at Exabeam, why ransomware is a popular strategy for attackers these days and how this is changing the landscape of available targets.

Abridged Thoughts:

This year, one ransomware landmark that illustrates that point well is the FBI sending its first-ever alert about a ransomware affiliate. A relatively new term, a ransomware affiliate, refers to a person or a group who rents access to ransomware as a service. They all orchestrate intrusions into a network, then encrypt the files with the “rented ransomware,” and they earn a commission, usually like 70 to 80 percent for successful extortions. Why is there this surge? One, it’s simple economics. It’s easy money. Two is opportunity. The huge and unplanned shift to home working during the pandemic was that final death nail.

Follow us on social media for the latest updates in B2B!

Image

Latest

Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More
Firefly
Pursuing the Impossible: The New Space Race with Firefly Aerospace Co-Founder Eric Salwan
April 1, 2026

Many companies set out to do something hard. Firefly Aerospace set out to do the impossible. After 10 years and several existential moments, Firefly did what no private company ever had: in 2025, it successfully landed on the Moon. Before Firefly, only countries had ever landed on the Moon—and it took extraordinary national effort…

Read More
internship
Tale of Two Interns: What AI Is Really Doing to Entry-Level Work
March 30, 2026

The narrative around early-career work has become increasingly pessimistic, with headlines pointing to a shrinking pool of entry-level roles, fewer internship opportunities, and AI accelerating both trends. But beneath that narrative, a different tension is emerging—one that’s less about the disappearance of opportunity and more about how it’s being reshaped. Students are using AI…

Read More